Product Program year 2025 Source: CMS Open Payments

Increlex

Drug Endocrinology

NDC 71863-216-04

Open in the dashboard

General payments

$93,911

289 payments

Research payments

$0

0 payments

Through program year 2025, $93,911 in general payments and $0 in research payments were reported against Increlex (Endocrinology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $93,911 289

Breakdown

Who paid General payments · program year 2025
  1. Eton Pharmaceuticals, Inc. $93,911 289 payments
Top recipients General payments · program year 2025
  1. Kanika Ghai Pediatric Endocrinology · Park Ridge, IL $25,629 27% · 1 payment
  2. Philippe Backeljauw Pediatric Endocrinology · Cincinnati, OH $18,155 19% · 1 payment
  3. Jadranka Popovic Pediatric Endocrinology · Pittsburgh, PA $6,672 7% · 1 payment
  4. Bradley Miller Pediatric Endocrinology · Minneapolis, MN $4,000 4% · 1 payment
  5. Courtney Finlayson Pediatric Endocrinology · Chicago, IL $3,138 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Endocrinology Pediatrics $84,806 91% · 161 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $3,672 4% · 21 practitioners
  3. Pediatrics $1,755 2% · 19 practitioners
  4. Adolescent Medicine Family Medicine $1,000 1% · 1 practitioner
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $684 <1% · 25 practitioners

The top 5 of 29 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $28,912 31% · 7 recipients
  2. Ohio $19,423 21% · 13 recipients
  3. Pennsylvania $6,781 7% · 3 recipients
  4. California $5,743 6% · 38 recipients
  5. Minnesota $5,706 6% · 3 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

289 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record